Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease

David J. Taber, E. Ashcraft, G. M. Baillie, S. Berkman, J. Rogers, P. K. Baliga, P. R. Rajagopalan, A. Lin, O. Emovon, F. Afzal, K. D. Chavin

Research output: Contribution to journal › Review article › peer-review